Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

24.44
Delayed Data
As of Aug 28
 +0.72 / +3.04%
Today’s Change
17.60
Today|||52-Week Range
42.26
-20.65%
Year-to-Date
No recent news for Relypsa Inc.

Today’s Trading

Previous close23.72
Today’s open23.68
Day’s range23.60 - 24.78
Volume428,428
Average volume (3 months)535,906
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+10.99%
Earnings growth (this year)-71.67%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.23

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.39+1.42%
CHRSCoherus BioSciences ...+0.44+1.54%
AIMTAimmune Therapeutics...-0.24-1.12%
ATRAAtara Biotherapeutic...+0.25+0.63%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$1.32
Annual revenue (last year)$0.00
Annual profit (last year)-$79.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Senior Vice President-
Pharmaceutical Operations
Wilhelm Stahl
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers